Genvec Inc (NASDAQ:GNVC)

CAPS Rating: 1 out of 5

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.

Recs

0
Player Avatar SmartAce (99.87) Submitted: 10/15/2013 2:49:50 PM : Underperform Start Price: $1.61 GNVC Score: +4.90

When life gives you lemons, give them to a two year old, it is hilarious.

Featured Broker Partners


Advertisement